BENTSUR RON
SEC insider (Form 3/4/5 filer). CIK 0001251213. Chairman & CEO at Nuvectis Pharma, Inc. (NVCT) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in FORT LEE, NJ.
Companies BENTSUR RON has filed insider reports for
- Nuvectis Pharma, Inc. (NVCT): Director, Officer, 10% Owner, Chairman & CEO
- Beyond Air, Inc. (XAIR): Director
BENTSUR RON
CIK: 0001251213
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 30, 2026NVCT
Nuvectis Pharma, Inc.
PurchaseDirect12.5K shares at avg. $20.00$250K - Jan 6, 2026NVCT
Nuvectis Pharma, Inc.
AwardDirect150K shares- - Nov 5, 2025NVCT
Nuvectis Pharma, Inc.
PurchaseDirect5K shares at avg. $5.72$29K - Jan 2, 2025NVCT
Nuvectis Pharma, Inc.
AwardDirect250K shares- - Dec 24, 2024NVCT
Nuvectis Pharma, Inc.
PurchaseDirect4.5K shares at avg. $4.65$21K - Nov 22, 2024XAIR
Beyond Air, Inc.
DispositionDirectStock Options (Right to buy)
30K shares- - Nov 22, 2024XAIR
Beyond Air, Inc.
AwardDirectStock Options (Right to buy)
30K shares- - Nov 22, 2024XAIR
Beyond Air, Inc.
DispositionDirectStock Options (Right to buy)
25K shares- - Nov 22, 2024XAIR
Beyond Air, Inc.
AwardDirectStock Options (Right to buy)
25K shares- - Nov 22, 2024XAIR
Beyond Air, Inc.
DispositionDirectStock Options (Right to buy)
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 |  NVCT Nuvectis Pharma, Inc. | Purchase | 12,500 | $20.00 | $250,000 | Direct |
| Jan 6, 2026 | NVCT Nuvectis Pharma, Inc. | Award | 150,000 | - | $0 | Direct |
| Nov 5, 2025 | NVCT Nuvectis Pharma, Inc. | Purchase | 5,000 | $5.72 | $28,600 | Direct |
| Jan 2, 2025 | NVCT Nuvectis Pharma, Inc. | Award | 250,000 | - | $0 | Direct |
| Dec 24, 2024 | NVCT Nuvectis Pharma, Inc. | Purchase | 4,500 | $4.65 | $20,925 | Direct |
| Nov 22, 2024 |  XAIR Beyond Air, Inc. | Disposition Stock Options (Right to buy) | 30,000 | - | - | Direct |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | Award Stock Options (Right to buy) | 30,000 | - | - | Direct |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | Disposition Stock Options (Right to buy) | 25,000 | - | - | Direct |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | Award Stock Options (Right to buy) | 25,000 | - | - | Direct |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | Disposition Stock Options (Right to buy) | 25,000 | - | - | Direct |
1-10 of 18 transactions